Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients
Multi-gene pharmacogenetic testing may be beneficial to gynecologic surgery/procedure patients by assisting clinicians with prescribing postoperative analgesics and future medications.
Authors
- Glenda Hoffecker (ORCID: https://orcid.org/0000-0002-7199-2196)
- Sony Tuteja (ORCID: https://orcid.org/0000-0001-7007-3289)
- Marjorie Risman
- Lakeisha Mulugeta‐Gordon
- Karl Keat (ORCID: https://orcid.org/0000-0002-0945-5816)
- Mary Deagostino‐Kelly
- Shefali S. Verma (ORCID: https://orcid.org/0000-0001-5216-4670)
Institutions
- Hospital of the University of Pennsylvania (US)
- California University of Pennsylvania (US)
- University of Pennsylvania Health System (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2024-10-12
- DOI
- https://doi.org/10.1080/14622416.2024.2428585
- Citations
- 1
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- University of Pennsylvania
- Regeneron Pharmaceuticals
- Georgia Clinical and Translational Science Alliance
- University of Pennsylvania Health System
- National Institutes of Health
- Perelman School of Medicine, University of Pennsylvania
- National Human Genome Research Institute
- National Center for Advancing Translational Sciences